Hanny Al-Samkari

Dr. Hanny Al-Samkari is a hematologist and clinical investigator at the Massachusetts General Hospital and Harvard Medical School. He specializes in disorders of bleeding and clotting as well as hemolytic anemias. This includes hereditary hemorrhagic telangiectasia, immune thrombocytopenia, chemotherapy-induced thrombocytopenia, pyruvate kinase deficiency, thalassemia, hemophilia, von Willebrand disease, and other blood diseases. As a clinical investigator, Dr. Al-Samkari serves as the principal investigator for several clinical trials at any given time for these diseases and is able to offer new treatment options to these patients.

Dr. Al-Samkari also serves as the Associate Director of the multidisciplinary Massachusetts General Hospital Hereditary Hemorrhagic Telangiectasia Center of Excellence.

He received his medical degree from Washington University in St. Louis, completed his residency in internal medicine at the Hospital of the University of Pennsylvania (where he also served as Chief Medical Resident), and completed his fellowship in hematology and medical oncology at the Dana-Farber Cancer Institute-Massachusetts General Hospital combined program.

Dr. Al-Samkari specializes in conducting research on non-malignant hematologic diseases, with a focus on disorders of hemostasis, thrombosis, and hemolysis. He runs clinical trials of new medications primarily in hereditary hemorrhagic telangiectasia (HHT), thrombocytopenias (disorders of low platelet count, including immune thrombocytopenia or ITP and chemotherapy-induced thrombocytopenia or CIT), hemophilia, and hereditary red cell disorders (including pyruvate kinase deficiency and thalassemia). He has published over 50 scholarly manuscripts and research abstracts in these areas and has presented numerous oral research presentations at national and international scientific conferences. which have been selected for a number of research awards.

Companies

• Assistant Professor Of Medicine Harvard Medical School (2021)
• Hematologist and Clinical Investigator Massachusetts General Hospital (2018)
• Instructor In Medicine Harvard Medical School (2018 — 2021)
• Chief Medical Resident Penn Medicine, University of Pennsylvania Health System (2014 — 2015)
• Instructor In Medicine University of Pennsylvania (2014 — 2015)

Education

• Fellowship in Hematology/Oncology, Dana-Farber Cancer Institute-Massachusetts General Hospital Harvard Medical School (Jun 2015 - Jun 2018)
• Internal Medicine Residency University of Pennsylvania (Jun 2011 - Jun 2014)
• Doctor of Medicine - MD Washington University in St. Louis (2007.08 — 2011.05)
• Bachelor of Arts - BA University of Dayton (2003.08 — 2007.05)
• Bachelor of Science - BS University of Dayton (2003.08 — 2007.05)